838 related articles for article (PubMed ID: 10577999)
1. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death.
Chalmers RA; Stanley CA; English N; Wigglesworth JS
J Pediatr; 1997 Aug; 131(2):220-5. PubMed ID: 9290607
[TBL] [Abstract][Full Text] [Related]
3. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
Stanley CA
Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
[TBL] [Abstract][Full Text] [Related]
5. Effects of fasting, feeding and exercise on plasma acylcarnitines among subjects with CPT2D, VLCADD and LCHADD/TFPD.
Elizondo G; Matern D; Vockley J; Harding CO; Gillingham MB
Mol Genet Metab; 2020; 131(1-2):90-97. PubMed ID: 32928639
[TBL] [Abstract][Full Text] [Related]
6. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death.
Chace DH; DiPerna JC; Mitchell BL; Sgroi B; Hofman LF; Naylor EW
Clin Chem; 2001; 47(7):1166-82. PubMed ID: 11427446
[TBL] [Abstract][Full Text] [Related]
7. Analysis of fatty acid oxidation intermediates in cultured fibroblasts to detect mitochondrial oxidation disorders.
Pourfarzam M; Schaefer J; Turnbull DM; Bartlett K
Clin Chem; 1994 Dec; 40(12):2267-75. PubMed ID: 7988014
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
[TBL] [Abstract][Full Text] [Related]
9. Long-chain fatty acid oxidation during early human development.
Oey NA; den Boer ME; Wijburg FA; Vekemans M; Augé J; Steiner C; Wanders RJ; Waterham HR; Ruiter JP; Attié-Bitach T
Pediatr Res; 2005 Jun; 57(6):755-9. PubMed ID: 15845636
[TBL] [Abstract][Full Text] [Related]
10. Lack of correlation between fatty acid oxidation disorders and haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome?
Holub M; Bodamer OA; Item C; Mühl A; Pollak A; Stöckler-Ipsiroglu S
Acta Paediatr; 2005 Jan; 94(1):48-52. PubMed ID: 15858960
[TBL] [Abstract][Full Text] [Related]
11. Follow-up of fatty acid β-oxidation disorders in expanded newborn screening era.
Janeiro P; Jotta R; Ramos R; Florindo C; Ventura FV; Vilarinho L; Tavares de Almeida I; Gaspar A
Eur J Pediatr; 2019 Mar; 178(3):387-394. PubMed ID: 30617651
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial fatty acid oxidation disorders in Thai infants: a report of 3 cases.
Wasant P; Matsumoto I; Naylor E; Liammongkolkul S
J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S710-9. PubMed ID: 12403251
[TBL] [Abstract][Full Text] [Related]
13. Analysis of mitochondrial fatty acid oxidation intermediates by tandem mass spectrometry from intact mitochondria prepared from homogenates of cultured fibroblasts, skeletal muscle cells, and fresh muscle.
Tyni T; Pourfarzam M; Turnbull DM
Pediatr Res; 2002 Jul; 52(1):64-70. PubMed ID: 12084849
[TBL] [Abstract][Full Text] [Related]
14. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life.
Boles RG; Buck EA; Blitzer MG; Platt MS; Cowan TM; Martin SK; Yoon H; Madsen JA; Reyes-Mugica M; Rinaldo P
J Pediatr; 1998 Jun; 132(6):924-33. PubMed ID: 9627580
[TBL] [Abstract][Full Text] [Related]
15. Muscle MRI in patients with long-chain fatty acid oxidation disorders.
Diekman EF; van der Pol WL; Nievelstein RA; Houten SM; Wijburg FA; Visser G
J Inherit Metab Dis; 2014 May; 37(3):405-13. PubMed ID: 24305961
[TBL] [Abstract][Full Text] [Related]
16. The safety of Lipistart, a medium-chain triglyceride based formula, in the dietary treatment of long-chain fatty acid disorders: a phase I study.
MacDonald A; Webster R; Whitlock M; Gerrard A; Daly A; Preece MA; Evans S; Ashmore C; Chakrapani A; Vijay S; Santra S
J Pediatr Endocrinol Metab; 2018 Mar; 31(3):297-304. PubMed ID: 29425111
[TBL] [Abstract][Full Text] [Related]
17. Retrospective review of Japanese sudden unexpected death in infancy: the importance of metabolic autopsy and expanded newborn screening.
Yamamoto T; Tanaka H; Kobayashi H; Okamura K; Tanaka T; Emoto Y; Sugimoto K; Nakatome M; Sakai N; Kuroki H; Yamaguchi S; Matoba R
Mol Genet Metab; 2011 Apr; 102(4):399-406. PubMed ID: 21227726
[TBL] [Abstract][Full Text] [Related]
18. Complications in early diagnosis and treatment of two infants with long-chain fatty acid beta-oxidation defects.
Skladal D; Sass JO; Geiger H; Geiger R; Mann C; Vreken P; Wanders RJ; Trawöger R
J Pediatr Gastroenterol Nutr; 2000 Oct; 31(4):448-52. PubMed ID: 11045847
[No Abstract] [Full Text] [Related]
19. Cardiologic evaluation of Turkish mitochondrial fatty acid oxidation disorders.
Balci MC; Karaca M; Ergul Y; Omeroglu RE; Demirkol M; Gokcay GF
Pediatr Int; 2022 Jan; 64(1):e15317. PubMed ID: 36331231
[TBL] [Abstract][Full Text] [Related]
20. Inherited defects of mitochondrial fatty acid oxidation.
Turnbull DM; Shepherd IM; Aynsley-Green A
Biochem Soc Trans; 1988 Jun; 16(3):424-7. PubMed ID: 3181618
[No Abstract] [Full Text] [Related]
[Next] [New Search]
